Sign In

Login

Password

Forgot Password ? Sign Up

Grindeks (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Grindeks" in Catalan language version.

refsWebsite
Global rank Catalan rank
5doi.org
2nd place
6th place
5nih.gov
4th place
7th place
4web.archive.org
1st place
1st place
4nasdaqomxbaltic.com
low place
low place
2archive.today
14th place
23rd place
1biotech-intelligence.com
low place
low place
1ceepharma.com
low place
low place
1evaluatepharma.com
low place
low place

archive.today

biotech-intelligence.com

ceepharma.com

doi.org

dx.doi.org

  • Sesti C, Simkhovich BZ, Kalvinsh I, Kloner RA «Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics». J. Cardiovasc. Pharmacol., 47, 3, 3-2006, pàg. 493–9. DOI: 10.1097/01.fjc.0000211732.76668.d2. PMID: 16633095.
  • Liepinsh E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, Dambrova M «Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction». J. Cardiovasc. Pharmacol., 48, 6, 12-2006, pàg. 314–9. DOI: 10.1097/01.fjc.0000250077.07702.23. PMID: 17204911.
  • Hayashi Y, Kirimoto T, Asaka N, Nakano M, Tajima K, Miyake H, Matsuura N «Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction». Eur. J. Pharmacol., 395, 3, 5-2000, pàg. 217–24. DOI: 10.1016/S0014-2999(00)00098-4. PMID: 10812052.
  • Leung IK, Krojer TJ, Kochan GT, Henry L, von Delft F, Claridge TD, Oppermann U, McDonough MA, Schofield CJ «Structural and mechanistic studies on γ-butyrobetaine hydroxylase». Chem. Biol., 17, 12, 12-2010, pàg. 1316–24. DOI: 10.1016/j.chembiol.2010.09.016. PMID: 21168767.
  • Tars K, Rumnieks J, Zeltins A, Kazaks A, Kotelovica S, Leonciks A, Sharipo J, Viksna A, Kuka J, Liepinsh E, Dambrova M «Crystal structure of human gamma-butyrobetaine hydroxylase». Biochem. Biophys. Res. Commun., 398, 4, 8-2010, pàg. 634–9. DOI: 10.1016/j.bbrc.2010.06.121. PMID: 20599753.

evaluatepharma.com

nasdaqomxbaltic.com

nih.gov

ncbi.nlm.nih.gov

  • Sesti C, Simkhovich BZ, Kalvinsh I, Kloner RA «Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics». J. Cardiovasc. Pharmacol., 47, 3, 3-2006, pàg. 493–9. DOI: 10.1097/01.fjc.0000211732.76668.d2. PMID: 16633095.
  • Liepinsh E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, Dambrova M «Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction». J. Cardiovasc. Pharmacol., 48, 6, 12-2006, pàg. 314–9. DOI: 10.1097/01.fjc.0000250077.07702.23. PMID: 17204911.
  • Hayashi Y, Kirimoto T, Asaka N, Nakano M, Tajima K, Miyake H, Matsuura N «Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction». Eur. J. Pharmacol., 395, 3, 5-2000, pàg. 217–24. DOI: 10.1016/S0014-2999(00)00098-4. PMID: 10812052.
  • Leung IK, Krojer TJ, Kochan GT, Henry L, von Delft F, Claridge TD, Oppermann U, McDonough MA, Schofield CJ «Structural and mechanistic studies on γ-butyrobetaine hydroxylase». Chem. Biol., 17, 12, 12-2010, pàg. 1316–24. DOI: 10.1016/j.chembiol.2010.09.016. PMID: 21168767.
  • Tars K, Rumnieks J, Zeltins A, Kazaks A, Kotelovica S, Leonciks A, Sharipo J, Viksna A, Kuka J, Liepinsh E, Dambrova M «Crystal structure of human gamma-butyrobetaine hydroxylase». Biochem. Biophys. Res. Commun., 398, 4, 8-2010, pàg. 634–9. DOI: 10.1016/j.bbrc.2010.06.121. PMID: 20599753.

web.archive.org